Actively Recruiting
Biomolecular Markers of Bone Metastasis
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-02-04
160
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to characterize the biomolecular profile of bone metastases to define the predisposing profiles of bone metastasis, in patients with breast or lung or renal carcinomas or of the gastroenteric or prostate tract with bone metastasis. The main question it aims to answer is: Is it possible to predict the progression of bone metastasis by identifying biomarkers as risk factors for bone metastasis?
CONDITIONS
Official Title
Biomolecular Markers of Bone Metastasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >= 18 years
- Diagnosis of breast, lung, renal, gastroenteric, or prostate carcinoma with bone metastases
- Ability and willingness to provide written informed consent to participate in the study
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
A
Andrea Sambri, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here